Leucinostatin Y
| Internal ID | 7e5448b7-5c12-429f-883c-c0085dfd29dc |
| Taxonomy | Organic acids and derivatives > Peptidomimetics > Hybrid peptides |
| IUPAC Name | 2-[3-[[2-[[2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-3-hydroxy-2-[[(2S)-6-hydroxy-4-methyl-2-[[(2S,4S)-4-methyl-1-(4-methylhex-2-enoyl)pyrrolidine-2-carbonyl]amino]-8-oxodecanoyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]propanoylamino]propanoic acid |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C60H104N10O15/c1-19-35(9)21-22-46(74)70-31-37(11)29-44(70)52(79)64-43(28-36(10)27-40(72)30-39(71)20-2)50(77)66-47(48(75)34(7)8)53(80)68-59(15,16)56(84)65-41(25-32(3)4)49(76)63-42(26-33(5)6)51(78)67-60(17,18)57(85)69-58(13,14)55(83)61-24-23-45(73)62-38(12)54(81)82/h21-22,32-38,40-44,47-48,72,75H,19-20,23-31H2,1-18H3,(H,61,83)(H,62,73)(H,63,76)(H,64,79)(H,65,84)(H,66,77)(H,67,78)(H,68,80)(H,69,85)(H,81,82)/t35?,36?,37-,38?,40?,41-,42-,43-,44-,47-,48?/m0/s1 |
| InChI Key | RNNIWZPLXMQCIS-COWGUVQBSA-N |
| Popularity | 1 reference in papers |
| Molecular Formula | C60H104N10O15 |
| Molecular Weight | 1205.50 g/mol |
| Exact Mass | 1204.76826265 g/mol |
| Topological Polar Surface Area (TPSA) | 377.00 Ų |
| XlogP | 3.80 |
| Atomic LogP (AlogP) | 1.80 |
| H-Bond Acceptor | 14 |
| H-Bond Donor | 12 |
| Rotatable Bonds | 36 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6587 | 65.87% |
| Caco-2 | - | 0.8617 | 86.17% |
| Blood Brain Barrier | - | 0.7000 | 70.00% |
| Human oral bioavailability | - | 0.7571 | 75.71% |
| Subcellular localzation | Mitochondria | 0.5463 | 54.63% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8279 | 82.79% |
| OATP1B3 inhibitior | + | 0.9121 | 91.21% |
| MATE1 inhibitior | - | 0.9600 | 96.00% |
| OCT2 inhibitior | - | 0.9750 | 97.50% |
| BSEP inhibitior | + | 0.9562 | 95.62% |
| P-glycoprotein inhibitior | + | 0.7425 | 74.25% |
| P-glycoprotein substrate | + | 0.8573 | 85.73% |
| CYP3A4 substrate | + | 0.7382 | 73.82% |
| CYP2C9 substrate | - | 0.8000 | 80.00% |
| CYP2D6 substrate | - | 0.8841 | 88.41% |
| CYP3A4 inhibition | - | 0.8488 | 84.88% |
| CYP2C9 inhibition | - | 0.8546 | 85.46% |
| CYP2C19 inhibition | - | 0.7868 | 78.68% |
| CYP2D6 inhibition | - | 0.9159 | 91.59% |
| CYP1A2 inhibition | - | 0.8833 | 88.33% |
| CYP2C8 inhibition | + | 0.7085 | 70.85% |
| CYP inhibitory promiscuity | - | 0.9128 | 91.28% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.8500 | 85.00% |
| Carcinogenicity (trinary) | Non-required | 0.6060 | 60.60% |
| Eye corrosion | - | 0.9857 | 98.57% |
| Eye irritation | - | 0.8965 | 89.65% |
| Skin irritation | - | 0.7746 | 77.46% |
| Skin corrosion | - | 0.8988 | 89.88% |
| Ames mutagenesis | - | 0.7000 | 70.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6778 | 67.78% |
| Micronuclear | + | 0.7000 | 70.00% |
| Hepatotoxicity | + | 0.5177 | 51.77% |
| skin sensitisation | - | 0.8680 | 86.80% |
| Respiratory toxicity | + | 0.6333 | 63.33% |
| Reproductive toxicity | + | 0.7222 | 72.22% |
| Mitochondrial toxicity | + | 0.7125 | 71.25% |
| Nephrotoxicity | - | 0.7116 | 71.16% |
| Acute Oral Toxicity (c) | III | 0.6367 | 63.67% |
| Estrogen receptor binding | + | 0.6437 | 64.37% |
| Androgen receptor binding | + | 0.7191 | 71.91% |
| Thyroid receptor binding | + | 0.6350 | 63.50% |
| Glucocorticoid receptor binding | + | 0.7294 | 72.94% |
| Aromatase binding | + | 0.7279 | 72.79% |
| PPAR gamma | + | 0.7946 | 79.46% |
| Honey bee toxicity | - | 0.6838 | 68.38% |
| Biodegradation | - | 0.7750 | 77.50% |
| Crustacea aquatic toxicity | - | 0.5776 | 57.76% |
| Fish aquatic toxicity | + | 0.8651 | 86.51% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.82% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.63% | 96.61% |
| CHEMBL221 | P23219 | Cyclooxygenase-1 | 98.54% | 90.17% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 98.31% | 89.63% |
| CHEMBL4801 | P29466 | Caspase-1 | 98.10% | 96.85% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 98.10% | 93.56% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 97.61% | 97.25% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 97.07% | 98.33% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 96.98% | 96.09% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 96.38% | 98.10% |
| CHEMBL236 | P41143 | Delta opioid receptor | 96.12% | 99.35% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 95.76% | 98.94% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 95.48% | 97.21% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 95.31% | 100.00% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 95.15% | 99.17% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 94.72% | 100.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 94.17% | 96.47% |
| CHEMBL4072 | P07858 | Cathepsin B | 93.63% | 93.67% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 93.23% | 90.71% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 92.46% | 100.00% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 92.31% | 95.52% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 92.24% | 98.05% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 91.61% | 97.50% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 91.32% | 97.14% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 91.25% | 97.29% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 91.24% | 97.64% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 91.21% | 89.50% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 91.17% | 87.16% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 91.15% | 93.10% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 90.54% | 96.00% |
| CHEMBL3776 | Q14790 | Caspase-8 | 90.44% | 97.06% |
| CHEMBL299 | P17252 | Protein kinase C alpha | 90.11% | 98.03% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 89.99% | 91.11% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 89.77% | 95.71% |
| CHEMBL3238 | P23786 | Carnitine palmitoyltransferase 2 | 88.57% | 94.05% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 88.18% | 96.67% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 88.17% | 91.19% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 88.11% | 96.95% |
| CHEMBL5979 | P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | 88.06% | 85.40% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 87.94% | 98.75% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 87.79% | 99.23% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 87.54% | 92.80% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 86.89% | 96.90% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 86.70% | 98.89% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 86.21% | 93.00% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 85.91% | 92.86% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 85.86% | 95.27% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 85.84% | 95.36% |
| CHEMBL4662 | P28074 | Proteasome Macropain subunit MB1 | 85.46% | 93.85% |
| CHEMBL2431 | P31751 | Serine/threonine-protein kinase AKT2 | 84.70% | 98.33% |
| CHEMBL2474 | P53582 | Methionine aminopeptidase 1 | 84.35% | 97.09% |
| CHEMBL5028 | O14672 | ADAM10 | 84.27% | 97.50% |
| CHEMBL4681 | P42330 | Aldo-keto-reductase family 1 member C3 | 84.16% | 89.05% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 84.01% | 96.67% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 83.82% | 97.50% |
| CHEMBL3468 | P55210 | Caspase-7 | 83.67% | 95.68% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 83.48% | 99.00% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 83.16% | 100.00% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 82.81% | 97.09% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 82.63% | 94.66% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 82.29% | 89.00% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 82.17% | 97.29% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 81.31% | 85.31% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 81.29% | 97.79% |
| CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 81.16% | 96.77% |
| CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 80.89% | 98.57% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 80.48% | 95.17% |
| CHEMBL5285 | Q99683 | Mitogen-activated protein kinase kinase kinase 5 | 80.44% | 92.26% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 80.34% | 96.33% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 80.32% | 97.23% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 80.29% | 96.28% |
| CHEMBL3055 | P50613 | Cyclin-dependent kinase 7 | 80.05% | 81.88% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 145720910 |
| LOTUS | LTS0149622 |
| wikiData | Q105241594 |